SPHRY

Starpharma Holdings Ltd.

 
Sponsored ADR (1 ADS : 10 Ordinary) International Reporting
OTCQX International
Verified Company Profile 1/12/2017
Contact Info
  • 4-6 Southampton Crescent
  • Abbotsford, VIC 3067
  • Australia

Business Description


 
Financial Reporting/Disclosure
Reporting Status International Reporting: ASX - Australian Securities Exchange
Audited Financials Audited
Latest Report Mar 31, 2017 Quarterly Report
CIK 0001308380
Fiscal Year End 6/30
OTC Marketplace OTCQX International
Profile Data
SIC - Industry Classification 8731 - Commercial physical research
Incorporated In: Australia
Year of Inc. 1997
Employees 40 a/o Jul 01, 2011
Company Officers/Contacts
Dr. Jackie Fairley CEO, IR, Managing Director
Nigel Baade CFO, Secretary
Company Directors
Robert Thomas Chairman
Richard Hazleton Independent Director, Audit Committee Member, Compensation Committee Member, Nominating Committee Member
Zita Peach
Peter Turvey
Service Providers
Accounting/Auditing Firm
PricewaterhouseCoopers
Level 19 Freshwater Place
2 Southbank Boulevard
Southbank, VIC, 3006
Australia
 
Securities Counsel

Not Available
Investor Relations Firm

Not Available
Company History
  • Sponsored for OTCQX by BNY Mellon on 3/26/2007.
  • Formerly=Starpharma Pooled Development Ltd. until 4-04
SPHRY Security Details Other Company Securities
Share Structure
Market Value1 $197,904,243 a/o Jun 22, 2017
Authorized Shares Unlimited a/o Dec 05, 2016
Outstanding Shares 368,536,766 a/o Dec 05, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value No Par Value
Transfer Agent(s)
BNY Mellon
Shareholders
Shareholders of Record 4,956 a/o Jul 31, 2016
Non US Stock Exchange Listing
SPL - ASX - Australian Securities Exchange - Qualified
Short Selling Data
Short Interest 1,599 (387.5%)
May 15, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security